Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. — PhagoDAIRI

Infection of Total Hip Joint Prosthesis Clinical Trial

Official title:
A Pilot, Multicenter, Randomized, Non-Comparative, Double-Blind Study of Phage Therapy in Patients With Hip or Knee Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR and Antibiotic Therapy.

Status Recruiting

Clinical Trial Summary

Pilot non comparative study assessing the clinical control of infection of DAIR + SAT +NaCl and DAIR + SAT + Phages anti-Staphylococcus aureus in patients with Staphylococcus aureus Prosthetic Joint Infection with an indication of DAIR + SAT.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Communicable Diseases
Infection of Total Hip Joint Prosthesis
Infection of Total Knee Joint Prosthesis
Infections

Clinical Trial Details

NCT number	NCT05369104
Study type	Interventional
Source	Pherecydes Pharma
Contact	Alexandra TIZON
Phone	+33184861613
Email	alexandra.tizon@pherecydes-pharma.com
Status	Recruiting
Phase	Phase 2
Start date	June 15, 2022
Completion date	June 16, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02594930` - Comparison of Two Different Techniques of Synovial Biopsy and Resistances of Cutaneous Smears in Suspected PPI	N/A
Completed	`NCT02019511` - Safety Study of High-dose Methylprednisolone in Fast-track Total Knee Arthroplasty
Not yet recruiting	`NCT04993027` - Topical Vancomycin for Infection Prophylaxis in TJA	Phase 2
Completed	`NCT02266407` - Surgical / Economic Effect of the Aquamantys System in Blood Management for Aseptic and Septic Revision TKA	N/A
Completed	`NCT03192124` - Evaluating Bactisure Wound Lavage in Orthopedic Wounds